Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Médecins Sans Frontières

• Oliver Yun,

  Affiliation Médecins Sans Frontières/Doctors Without Borders, New York, New York, United States of America

  ⨯
• M. Angeles Lima ,

  * E-mail: nines.lima@barcelona.msf.org

  Affiliation Médecins Sans Frontières, Operational Center Barcelona-Athens (OCBA), Barcelona, Spain

  ⨯
• Tom Ellman,

  Affiliation Médecins Sans Frontières/Médicos Sin Fronteras, La Paz, Bolivia

  ⨯
• Wilma Chambi,

  Affiliation Médecins Sans Frontières/Médicos Sin Fronteras, La Paz, Bolivia

  ⨯
• Sandra Castillo,

  Affiliation Médecins Sans Frontières/Médicos Sin Fronteras, La Paz, Bolivia

  ⨯
• Laurence Flevaud,

  Affiliation Médecins Sans Frontières, Operational Center Barcelona-Athens (OCBA), Barcelona, Spain

  ⨯
• Paul Roddy,

  Affiliation Médecins Sans Frontières, Operational Center Barcelona-Athens (OCBA), Barcelona, Spain

  ⨯
• Fernando Parreño,

  Affiliation Médecins Sans Frontières, Operational Center Barcelona-Athens (OCBA), Barcelona, Spain

  ⨯
• Pedro Albajar Viñas,

  Affiliation Laboratory of Parasitological Diseases, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

  ⨯
• Pedro Pablo Palma

  Affiliation Médecins Sans Frontières, Operational Center Barcelona-Athens (OCBA), Barcelona, Spain

  ⨯